| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5888361 | Experimental and Molecular Pathology | 2014 | 6 Pages |
Abstract
In conclusion, angiosarcomas express multiple angiogenic growth factors. Treatments could be targeted at individual angiogenic growth factors. However, our findings provide a rationale for combination therapy, or for treatments that target common downstream signalling intermediaries, such as Akt, mTOR or ERK.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Robin J. Young, Malee Fernando, David Hughes, Nicola J. Brown, Penella J. Woll,